688399
vs
S
Shanghai Composite
688399
Over the past 12 months, Jiangsu Bioperfectus Technologies Co Ltd has underperformed Shanghai Composite, delivering a return of -7% compared to the Shanghai Composite's +14% growth.
Stocks Performance
688399 vs Shanghai Composite
Performance Gap
688399 vs Shanghai Composite
Performance By Year
688399 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Jiangsu Bioperfectus Technologies Co Ltd
Glance View
Jiangsu Bioperfectus Technologies Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents and supporting testing instruments. The company is headquartered in Taizhou, Jiangsu and currently employs 765 full-time employees. The company went IPO on 2019-12-05. The firm's products mainly include in vitro diagnostic reagents, supporting testing instruments and in vitro testing services. Its products are mainly used in the fields of infectious disease prevention and control, clinical testing, large-scale population screening, as well as prenatal and postnatal care management. The firm mainly conducts its businesses in domestic and overseas markets.